Canopy Growth Corp Income (Loss) from Equity Method Investments
Canopy Growth Corp (CGC) reported Income (Loss) from Equity Method Investments of -CAD 100.00 thousand for the 12-month period ending 2022-03-31, per its 10-K filed 2024-05-30.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2024-05-30
- Canopy Growth Corp income (loss) from equity method investments for the quarter ending 2022-03-31 was 0.00 CAD.
- Canopy Growth Corp income (loss) from equity method investments for the quarter ending 2021-12-31 was 0.00 CAD.
- Canopy Growth Corp income (loss) from equity method investments for the quarter ending 2021-09-30 was 0.00 CAD.
- Canopy Growth Corp income (loss) from equity method investments for the quarter ending 2021-06-30 was -100.00K CAD.
- Canopy Growth Corp income (loss) from equity method investments for fiscal 2022 was -100.00K CAD.
- Canopy Growth Corp income (loss) from equity method investments for fiscal 2021 was -52.63M CAD.
- Canopy Growth Corp income (loss) from equity method investments for fiscal 2020 was -64.42M CAD.
- Canopy Growth Corp income (loss) from equity method investments for fiscal 2019 was -10.75M CAD.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2022-03-31 | 0.00 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-30 | 0.00 CAD derived: sum of 2 quarters · filed 2024-05-30 | 0.00 CAD derived: sum of 3 quarters · filed 2024-05-30 | -100.00K CAD 10-K · filed 2024-05-30 |
| 2021-12-31 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 0.00 CAD derived: sum of 2 quarters · filed 2023-02-09 | -100.00K CAD 10-Q · filed 2023-02-09 | -11.88M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-09-30 | 0.00 CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | -100.00K CAD 10-Q · filed 2022-11-09 | -11.88M CAD derived: sum of 3 quarters · filed 2023-06-22 | -12.55M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-06-30 | -100.00K CAD 10-Q · filed 2022-08-09 | -11.88M CAD derived: sum of 2 quarters · filed 2023-06-22 | -12.55M CAD derived: sum of 3 quarters · filed 2023-06-22 | -45.54M CAD derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-03-31 | -11.78M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | -12.45M CAD derived: sum of 2 quarters · filed 2023-06-22 | -45.44M CAD derived: sum of 3 quarters · filed 2023-06-22 | -52.63M CAD 10-K · filed 2023-06-22 |
| 2020-12-31 | -671.00K CAD 10-Q · filed 2022-02-09 | -33.66M CAD derived: sum of 2 quarters · filed 2022-02-09 | -40.85M CAD 10-Q · filed 2022-02-09 | -98.60M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-09-30 | -32.99M CAD 10-Q · filed 2021-11-08 | -40.18M CAD 10-Q · filed 2021-11-08 | -97.93M CAD derived: sum of 3 quarters · filed 2022-05-31 | -100.60M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-06-30 | -7.19M CAD 10-Q · filed 2021-08-06 | -64.94M CAD derived: sum of 2 quarters · filed 2022-05-31 | -67.61M CAD derived: sum of 3 quarters · filed 2022-05-31 | -69.78M CAD derived: sum of 4 quarters · filed 2022-05-31 |
| 2020-03-31 | -57.75M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | -60.42M CAD derived: sum of 2 quarters · filed 2022-05-31 | -62.59M CAD derived: sum of 3 quarters · filed 2022-05-31 | -64.42M CAD 10-K · filed 2022-05-31 |
| 2019-12-31 | -2.66M CAD 10-Q · filed 2021-02-09 | -4.83M CAD derived: sum of 2 quarters · filed 2021-02-09 | -6.67M CAD 10-Q · filed 2021-02-09 | |
| 2019-09-30 | -2.17M CAD 10-Q · filed 2020-11-09 | -4.00M CAD 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -1.83M CAD 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | -10.75M CAD 10-K · filed 2021-06-01 | |||
| 2018-03-31 | -1.47M CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |